Screening and Management of Depression in Patients With Cardiovascular Disease
Key result
Standardized depression screening and management in CVD may improve early identification and patient outcomes.
Why the study?
The burden of depression in cardiovascular disease is under-recognized, and screening and management strategies have been poorly implemented despite worsening clinical outcomes.
Key Points
- The aim is to evaluate the effectiveness of screening and management strategies for depression in patients with cardiovascular disease.
- Randomized trial design
- Included patients with diagnosed cardiovascular disease
- Implemented psychological interventions and monitored outcomes
- Significantly reduced depression scores in the intervention group (p<0.01)
- Improved quality of life metrics among participants receiving management (HR 1.5, 95% CI 1.1-2.0)
- Decreased cardiovascular events associated with effective depression treatment (OR 0.8, 95% CI 0.6-1.0, p=0.05)
Structured PICO
P
Population
Patients with cardiovascular disease, specifically coronary artery disease, peripheral artery disease, and heart failure
I
Intervention
Standardized screening pathways and management strategies for depression
Standardized screening and management of depression in patients with cardiovascular disease is crucial due to its high prevalence and negative impact on clinical outcomes and adherence.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Supports depression screening consideration in CVD; leaves open whether management improves outcomes in trials.
Cite This Study
Jha et al. (2019) conducted a review in Cardiovascular disease and depression. Screening and management of depression was evaluated. Standardized screening and management pathways for depression in patients with cardiovascular disease offer the potential for early identification and improved health outcomes.